Rémi Fromentin
Impact in
- Virology top 0.1%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
- Virology 58
- HIV Research and Treatment 58
- Immunology 28
- Immune Cell Function and Interaction 28
- T-cell and B-cell Immunology 10
- Co-authors
- Nicolas Chomont (61 shared papers)Jean‐Pierre Routy (19 shared papers)Steven G. Deeks (17 shared papers)Rafick‐Pierre Sékaly (8 shared papers)Frederick Hecht (11 shared papers)Rebecca Hoh (11 shared papers)Marta Massanella (7 shared papers)Sandrina DaFonseca (4 shared papers)
- Journals
- PLoS Pathogens (7 papers)AIDS (7 papers)The Journal of Infectious Diseases (6 papers)Journal of Virology (4 papers)Journal of Virus Eradication (4 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Rémi Fromentin
68 papers receiving 4.3k citations
Rémi Fromentin's Hit Papers
Peers
Comparison fields: 5 of 94
- Virology 3.2k
- Infectious Diseases 1.6k
- Immunology 1.5k
- Emergency Medicine 321
- Epidemiology 737
Countries citing papers authored by Rémi Fromentin
This map shows the geographic impact of Rémi Fromentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rémi Fromentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rémi Fromentin more than expected).
Fields of papers citing papers by Rémi Fromentin
This network shows the impact of papers produced by Rémi Fromentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rémi Fromentin. The network helps show where Rémi Fromentin may publish in the future.
Co-authors
The 25 scholars most cited alongside Rémi Fromentin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo Hit paper breakdown → | 2015 | 382 |
| 2 | 2016 | 317 | |
| 3 | 2017 | 275 | |
| 4 | 2013 | 186 | |
| 5 | 2015 | 186 | |
| 6 | 2015 | 186 | |
| 7 | 2012 | 161 | |
| 8 | 2019 | 159 | |
| 9 | 2014 | 157 | |
| 10 | 2019 | 155 | |
| 11 | 2016 | 143 | |
| 12 | 2018 | 124 | |
| 13 | 2016 | 106 | |
| 14 | 2015 | 104 | |
| 15 | 2014 | 87 | |
| 16 | 2016 | 78 | |
| 17 | 2017 | 74 | |
| 18 | 2013 | 72 | |
| 19 | 2020 | 72 | |
| 20 | 2016 | 61 |
About Rémi Fromentin
Rémi Fromentin is a scholar working on Virology, Immunology, Infectious Diseases, Epidemiology and Emergency Medicine, having authored 70 papers that have together received 4.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (58 papers), Immune Cell Function and Interaction (28 papers), HIV/AIDS drug development and treatment (13 papers), T-cell and B-cell Immunology (10 papers), Cytomegalovirus and herpesvirus research (8 papers), HIV/AIDS Research and Interventions (6 papers), HIV-related health complications and treatments (6 papers) and Hepatitis C virus research (5 papers). The work is most often cited by research in Virology (3.2k citations), Infectious Diseases (1.6k citations), Immunology (1.5k citations), Emergency Medicine (321 citations) and Epidemiology (737 citations). Rémi Fromentin has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Nicolas Chomont, Jean‐Pierre Routy, Steven G. Deeks, Rafick‐Pierre Sékaly, Frederick Hecht, Rebecca Hoh, Marta Massanella, Sandrina DaFonseca, Sharon R. Lewin and Wendy Bakeman. Their work appears in journals such as PLoS Pathogens, AIDS, The Journal of Infectious Diseases, Journal of Virology and Journal of Virus Eradication.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.